Mediating effect analysis of visceral adiposity index on free triiodothyronine to free thyroxine ratio and non-alcoholic fatty liver disease in euthyroid population

被引:0
|
作者
Liu, Huan-Xin [1 ]
Ren, Yan-Yan [2 ]
Meng, Cui-Qiao [1 ]
Li, Zhong [3 ]
Nie, Qian [1 ]
Yu, Chun-Hong [1 ]
Ma, Hui-Juan [4 ,5 ]
机构
[1] Hebei Gen Hosp, Hlth Examinat Ctr, Shijiazhuang, Peoples R China
[2] Hebei Gen Hosp, Dept Neurol, Shijiazhuang, Peoples R China
[3] Shijiazhuang peoples Hosp, Dept Gen Surg, Shijiazhuang, Peoples R China
[4] Hebei Gen Hosp, Key Lab Metab Dis Hebei Prov, Shijiazhuang, Peoples R China
[5] Hebei Gen Hosp, Dept Endocrinol, Shijiazhuang, Peoples R China
来源
关键词
visceral adiposity index; free triiodothyronine to free thyroxine ratio; non-alcoholic fatty liver disease; thyroid function; mediating effect; METABOLIC PARAMETERS; INSULIN-RESISTANCE; THYROID-HORMONES; PREDICTOR;
D O I
10.3389/fendo.2022.961803
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThe association between free triiodothyronine/free thyroxine (FT3/FT4) and non-alcoholic fatty liver disease (NAFLD) in euthyroid subjects is unclear. In addition, few studies have explored whether VAI mediates the association between FT3/FT4 ratio and NAFLD in the euthyroid population. We aimed to analyze the mediating effect of VAI on the FT3/FT4 ratio and NAFLD risk in the euthyroid population. MethodsThis cross-sectional study included 7 946 annual health examinees from the Health Examination Center, Hebei General Hospital, from January to December 2020. The basic information and biochemical parameters, as well as calculated FT3/FT4 ratio and VAI were collected. NAFLD was diagnosed according to abdominal ultrasonography. The fibrosis score for NAFLD positive subjects (NFS) was calculated to reflect the extent of liver fibrosis. The risk of NAFLD was analyzed by quartiles of FT3/FT4 ratio (Q1-Q4 quartiles) and VAI (V1-V4 quartiles), respectively. Pearson correlation analysis was performed to investigate the correlation between FT3/FT4 ratio and VAI. Multivariate logistic regression analysis was applied to analyze the effect of FT3/FT4 ratio and VAI on NAFLD and NFS status. Bootstrap was conducted to explore whether VAI mediated the association between FT3/FT4 ratio and NAFLD. ResultsOf the 7 946 participants, 2 810 (35.36%) had NAFLD and 5 136 (64.64%) did not. Pearson correlation analysis indicated that FT3/FT4 ratio was positively associated with VAI (P<0.05). Multivariate logistic regression analysis indicated that compared to the Q1 group, the risk of NAFLD significantly increased in Q3 group [OR=1.255, 95%CI (1.011, 1.559)] and Q4 group [OR=1.553, 95%CI (1.252, 1.926)](P<0.05). Compared to the V1 group, the risk of NAFLD notably increased in V2 group [OR=1.584, 95%CI (1.205, 2.083)], V3 group [OR=2.386, 95%CI (1.778, 3.202)] and V4 group [OR=4.104, 95%CI (2.835, 5.939)] (P<0.01). There was no relevance between FT3/FT4 ratio, VAI and NFS status. Mediating effect analysis showed that FT3/FT4 ratio significantly directly influenced NAFLD prevalence [beta=3.7029, 95%CI (2.9583, 4.4474)], and VAI partly mediated the indirect effect of the FT3/FT4 ratio on NAFLD prevalence [beta=2.7649, 95%CI (2.2347, 3.3466)], and the mediating effect accounted for 42.75% of the total effects. ConclusionBoth FT3/FT4 ratio and VAI were predictors of NAFLD, and VAI partly mediated the indirect effect of the FT3/FT4 ratio on NAFLD prevalence in the euthyroid population.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Comparison of fatty liver index with fibroscan in non-alcoholic fatty liver disease
    Ahmed, Marium
    Saeed, Rabeeya
    Kamani, Lubna
    Durrani, Noureen
    Ahmed, Faraz
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2024, 13 (04) : 1488 - 1495
  • [32] Association between visceral adipocyte size and non-alcoholic fatty liver disease in subjects with different degrees of adiposity
    Sun, H.
    Gu, T.
    Fang, D.
    Yuan, Y.
    Wang, H.
    Bi, Y.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S440 - S441
  • [33] The metabolic triad of non-alcoholic fatty liver disease, visceral adiposity and type 2 diabetes: Implications for treatment
    Cariou, Bertrand
    DIABETES OBESITY & METABOLISM, 2022, 24 : 15 - 27
  • [34] Non-alcoholic fatty liver disease as a visceral manifestation of metabolic syndrome
    Roecken, C.
    GASTROENTEROLOGE, 2013, 8 (06): : 517 - 524
  • [35] Performance of Fatty Liver Index in Identifying Non-Alcoholic Fatty Liver Disease in Population Studies. A Meta-Analysis
    Castellana, Marco
    Donghia, Rossella
    Guerra, Vito
    Procino, Filippo
    Lampignano, Luisa
    Castellana, Fabio
    Zupo, Roberta
    Sardone, Rodolfo
    De Pergola, Giovanni
    Romanelli, Francesco
    Trimboli, Pierpaolo
    Giannelli, Gianluigi
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (09)
  • [36] Free triiodothyronine is associated with the occurrence and remission of nonalcoholic fatty liver disease in euthyroid women
    Chen, Peizhu
    Hou, Xuhong
    Wei, Li
    Feng, Liang
    Zhong, Lichang
    Jiao, Lei
    Wang, Hongmei
    Bao, Yuqian
    Jia, Weiping
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 (04)
  • [37] Ultrasonographic index for the diagnosis of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease
    Kim, Jeong Woo
    Lee, Chang Hee
    Kim, Baek-Hui
    Lee, Young-Sun
    Hwang, Soon-Young
    Park, Bit Na
    Park, Yang Shin
    QUANTITATIVE IMAGING IN MEDICINE AND SURGERY, 2022, 12 (03) : 1815 - 1829
  • [38] The use of the fatty liver index and fibroscan to determine the prevalence of non-alcoholic fatty liver disease in an Irish population
    Rabbitt, Louise
    Mcnally, Mairead
    Bohan-Keane, Mary
    Scarry, Margaret
    Reynolds, Laura
    Hinchion, Kate
    Goulding, Carol
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E780 - E781
  • [39] TRIGLYCERIDE AND GLUCOSE INDEX IN NON-ALCOHOLIC FATTY LIVER DISEASE
    Salehabadi, Sepideh
    Sathyapalan, Thozhukat
    Almahmeed, Wael
    Al-Rasadi, Khalid
    Emadzadeh, Maryam
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    ATHEROSCLEROSIS, 2024, 399
  • [40] Effect of omega-3 supplementation on fatty liver and visceral adiposity indices in diabetic patients with non-alcoholic fatty liver disease: A randomized controlled trial
    Sangouni, Abbas Ali
    Orang, Zahra
    Mozaffari-Khosravi, Hassan
    CLINICAL NUTRITION ESPEN, 2021, 44 : 130 - 135